1. Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 1986;38:21–43.
2. Alvarez FJ, Sancho M, Vega J, Del Rio MC, Rams MA, Queipo D. Drugs other alcohol (medicines and illicit drugs) in people involved in fatal road accidents in Spain. In: Mercier-Guyon C, Ed. Alcohol, Drugs and Safety — T’97. Annecy, CERMT Annecy, 1997, pp. 677–682. Zitiert nach: Maes et al. 1999.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association, 1994.
4. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;2:1483–1486.
5. Atha MJ, Blanchard S, Davis S. Cannabis and driving [abstract]. Wigan/Großbritannien: Independent Drug Monitoring Unit, April 2000. Verfügbar im Internet: http://www.idmu.co.uk/candrivab.htm